Dr. Raman Tuli

Uczestniczy w 5 elementy

Elementy, w których Dr. Raman Tuli uczestniczy

sobota 26 czerwiec, 2021

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

Faricimab in Neovascular Age-Related Macular Degeneration: One-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials

15:51 - 15:59 | 8 min.

Dr. Raman Tuli (Speaker)

niedziela 27 czerwiec, 2021

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab(PDS) for Patients With Neovascular AMD

16:07 - 16:15 | 8 min.

Dr. Raman Tuli (Speaker)

piątek 16 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

Efficacy of intravitreal pegcetacoplan in geographic atrophy: 24-month results from the Phase 3 OAKS and DERBY trials

13:46 - 13:53 | 7 min.

Québec City Convention Centre - Room 307 AB | Salle 307 AB

Dr. Raman Tuli (Presenter)

piątek 20 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months Including 12-Month Results of the GALE Open-Label Extension Study - 5561

11:32 - 11:37 | 5 min.

Vancouver Convention Centre (East Building) - Ballroom B

Dr. Raman Tuli (Speaker)

11:37 - 11:40 | 3 min.

Vancouver Convention Centre (East Building) - Ballroom B